Part of the Oncology Commons
An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents, Sarina A. Piha-Paul Dissertations and Theses (Open Access)
PDF
Advanced Search
